CASTL partners with Ireland's NIBRT to provide accredited biomanufacturing training, addressing Canada's skilled worker ...
Industry experts at Cell Summit 2026 say the public lacks understanding of biologics and growing distrust poses challenges ...
A key theme emerging from FDA complete response letters since 2018 is that data system validation is lacking in the ...
BioProcess International learned about how advanced therapy developers and manufacturers are adapting to changing ...
Earlier this week, contract development and manufacturing organization (CDMO) Cellares announced its partnership with ...
Ralph Brandenberger of Dark Horse Consulting Group told delegates at the Cell Summit that insufficient planning causes delays ...
BPI Contributor Sidharth Ananthanarayan ...
The FDA’s May 2026 guidance on cell and gene therapies provides for CMC flexibilities while insisting on quality and ...
Abu Sadat Muhammod Saiyem, BPI contributor ...
BPI Contributor Jeisa Pelet ...
In its Q4 earnings call to investors on February 25, vaccine developer Vaxcyte expressed optimism about its VAX-31 invasive pneumococcal disease (IPD) vaccine program and discussed the company’s ...
Biopharmaceutical organizations are seeking out ways to increase predictability in clonal material generated during cell line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results